Levodopa and carbidopa intestinal gel and methods of use
US10117843B2 · kind B2 · utility
4Cited by
7References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2016 |
| Grant date | Nov 6, 2018 |
| Priority date | — |
| Expiry date | Jan 20, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to (a) an improved pharmaceutical composition comprising a levodopa active agent and a carbidopa active agent (b) methods of producing the pharmaceutical composition and (c) methods of treating Parkinson's disease and associated conditions comprising administering the pharmaceutical composition to a subject with Parkinson's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.